(R)-2-(2,5-Dichlorophenyl)pyrrolidine hydrochloride, 98%, 5g

Methyl 2-methyl-2-(4-nitrophenyl)propanoate, 97%, 10g

Transfer membrane ROTI®PVDF 0.45

4-Chloro-6-(methoxymethyl)-2-(methylthio)pyrimidine, 95.0%, 250mg

2-Methyl-4-(2-thienyl)-1,3-thiazole, 95%, 10g

6-Bromo-2-methoxypyridin-3-ol, 98%, 1g

Tert-butyl 4-cyano-4-(3-fluorophenyl)piperidine-1-carboxylate, 98%, 1g

alpha-Methylene-gamma-butyrolactone (stabilized with 2,6-Di-tert-butyl-p-cresol)>95.0%(GC)25g

2-{[(4-chlorophenyl)amino]carbonyl}cyclohexanecarboxylic acid, 95.0%, 5g

6,7-dibromo-1H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one, 97%, 5g

Palbociclib isethionate, 95%, 100mg

(3R,4S)-1-PIPERIDINECARBOXYLIC ACID, 3-AMINO-4-HYDROXY-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 250mg

2,2'-(Piperazine-1,4-diyl)diethanol, 95.0%, 25g